Dr. Lal Pathlabs Ltd. (LALPATHLAB): Dr. Lal Pathlabs Share Price Rises 2.34% to Rs 1,967.60
- September 24, 2026
- Posted by: Harsh Piplani
- Category: News
Dr. Lal Pathlabs Share Price moved higher today, with the stock closing at Rs 1,967.60 after a gain of 2.34% from the previous close of Rs 1,922.60. The company’s market capitalisation now stands at Rs 32,076.75 Cr, placing this as a notable share price rise within today’s Healthcare stock news flow. The verified data confirms the price event, while no company-specific catalyst is supplied in the dataset.
For readers tracking Dr. Lal Pathlabs Share Price Today, the move came after an intraday range that touched Rs 1,913.25 on the lower side and Rs 1,967.60 on the higher side, with turnover of Rs 2.37 Cr. That combination gives a factual read on today’s share price update without adding unverified reasons. In Univest coverage terms, the stock is appearing in Stocks in News because of the same-day gain, and investors can use the numbers below to assess whether the current Dr. Lal Pathlabs Share Price news is better understood through valuation, sector context and relative comparison than through any assumed trigger.
Dr. Lal Pathlabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,967.6 |
| Previous Close | Rs 1,922.6 |
| Today's Move | Rs 45 (+2.34%) |
| Open | Rs 1,920.15 |
| High | Rs 1,967.6 |
| Low | Rs 1,913.25 |
| Turnover | Rs 2.37 crore |
| Market Capitalisation | Rs 32,076.75 crore |
| Market Cap Category | Large Cap |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) rose to Rs 1,967.6 from the previous close of Rs 1,922.6, a move of Rs 45 or 2.34%. The stock opened at Rs 1,920.15, reached a high of Rs 1,967.6, recorded a low of Rs 1,913.25.
Dr. Lal Pathlabs Share Price opened at Rs 1,920.15, moved between Rs 1,913.25 and Rs 1,967.60, and ended the session at Rs 1,967.60. That leaves the stock Rs 45 higher than the previous close of Rs 1,922.60, equal to a 2.34% share price rise for the day. The close also matched the day high, which makes today’s Dr. Lal Pathlabs Share Price Today move straightforward to read from the published figures. The data confirms a positive price action day, but it does not establish a company-specific driver. For anyone scanning Dr. Lal Pathlabs Stock News or Dr. Lal Pathlabs Share News, the event is best treated as a verified daily move rather than a story with an identified cause.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 32,076.75 crore |
| P/E Ratio | 59.55x |
| P/B Ratio | 12.35x |
| ROE | 22.37% |
| ROCE | 29.56% |
| EPS | Rs 32.29 |
| Book Value Per Share | Rs 155.67 |
| Dividend Yield | 1.07% |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) fundamental metrics show P/E 59.55x, P/B 12.35x, ROE 22.37%, ROCE 29.56%. These figures provide context only and are not a buy or sell signal.
Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 32076.75 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.55x, P/B at 12.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.07%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 48.15x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 59.55x |
| Benchmark Median P/E | 48.15x |
| Benchmark Average P/E | 102.87x |
| Benchmark P/E Range | 6.91x to 1,616.57x |
| Company P/B Ratio | 12.35x |
| Benchmark Median P/B | 3.99x |
| Company ROE | 22.37% |
| Benchmark Median ROE | 13.01% |
| Company ROCE | 29.56% |
| Benchmark Median ROCE | 15.84% |
| Company Market Capitalisation | Rs 32,076.75 crore |
| Benchmark Median Market Cap | Rs 553.23 crore |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 59.55x, which is above the benchmark median of 48.15x, a difference of +23.68%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 13.01%, a difference of +71.94%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.84%, a difference of +86.62%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP | 1,27,792.21 | 62.35 | 13.45 | 23.54 | 21.73 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 1,03,068.69 | 70.32 | 9.37 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 98,160.02 | 112.09 | 5.48 | 12.95 | 13.93 |
| Fortis Healthcare Ltd. | FORTIS | 67,512.13 | 64.19 | 6.62 | 11.32 | 14.07 |
| Aster DM Healthcare Ltd. | ASTERDM | 65,493.11 | 208.03 | 15.67 | 13.07 | 16.22 |
Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P/E ratio of 59.55x compared with the displayed peer median of 70.32x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 32,076.75 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Dr. Lal Pathlabs
- Dr. Lal Pathlabs Share Price rose 2.34% today to Rs 1,967.60 from Rs 1,922.60.
- The stock finished at the day high of Rs 1,967.60 after opening at Rs 1,920.15.
- Market capitalisation stands at Rs 32,076.75 Cr, which is above the industry median in the supplied set.
- P/E is 59.55 and P/B is 12.35, both important valuation markers for Dr. Lal Pathlabs Fundamental Analysis.
- ROE of 22.37% and ROCE of 29.56% provide profitability and capital-efficiency context for the current share price.
About Dr. Lal Pathlabs
Dr. Lal Pathlabs Ltd. is part of the Healthcare sector and the Hospital & Healthcare Services industry in the supplied dataset. The company is evaluated here through its listed-market metrics rather than a broader corporate profile, so the focus stays on what can be verified: current share price, valuation, profitability and industry comparison. That makes the stock relevant for readers who track Dr. Lal Pathlabs Stock News, Dr. Lal Pathlabs Latest News and Dr. Lal Pathlabs Share Price Update on Univest.
The business context used in this article comes from the industry framework supplied with the data. In simple terms, the current Dr. Lal Pathlabs Share Price matters because it sits inside a valuation structure that can be compared with other hospital and healthcare services names in the Indian stock market.
Track Dr. Lal Pathlabs Share Price on Univest
Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
For investors scanning Dr. Lal Pathlabs Stock News or Dr. Lal Pathlabs Stock Gaining Today headlines, Univest keeps the focus on verified market data, not speculation. The same page can be used for share price news, company news, stock performance checks and broader market context when needed.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Dr. Lal Pathlabs Share Price rise today?
Ans. The dataset confirms a 2.34% rise to Rs 1,967.60, but it does not provide a company-specific catalyst. The article therefore treats the move as a verified same-day price event. The previous close was Rs 1,922.6.
What is Dr. Lal Pathlabs Share Price today?
Ans. Dr. Lal Pathlabs Share Price today is Rs 1,967.60. It closed Rs 45 above the previous close of Rs 1,922.60 and matched the day high in the supplied data. The previous close was Rs 1,922.6.
How much did Dr. Lal Pathlabs stock rise today?
Ans. The stock rose Rs 45 or 2.34% during the session. That move is measured from the previous close of Rs 1,922.60 to the latest closing price of Rs 1,967.60. The previous close was Rs 1,922.6.
What is Dr. Lal Pathlabs market capitalisation?
Ans. Dr. Lal Pathlabs has a market capitalisation of Rs 32,076.75 Cr. In the supplied healthcare benchmark, that is well above the industry median and above the industry average. The company operates in the Healthcare sector.
Is Dr. Lal Pathlabs expensive on valuation?
Ans. The stock trades at a P/E of 59.55 and a P/B of 12.35. Compared with the industry median and average, those are rich multiples, though profitability metrics are also strong.
What do Dr. Lal Pathlabs ROE and ROCE show?
Ans. ROE is 22.37% and ROCE is 29.56%. Both numbers are above the supplied industry medians, which gives useful context for Dr. Lal Pathlabs Fundamental Analysis and share price review. ROE stands at 22.37%.
How does Dr. Lal Pathlabs compare with healthcare peers?
Ans. Dr. Lal Pathlabs has a P/E below several healthcare peers and a ROCE higher than all supplied peers. Its market cap also places it among the larger names in the comparison set.
What should investors track next in Dr. Lal Pathlabs Share Price?
Ans. Investors can track future price action, valuation multiples, and any fresh company news on Univest. The current data supports a focus on fundamentals and sector comparison rather than on an identified trigger.
